Bone remodeling and hematopoiesis are interrelated and bone marrow (BM) macrophages are considered to be important for both bone remodeling and maintenance of the hematopoietic niche. We found that NF-κB Rela-deficient chimeric mice, generated by transplanting Rela −/− fetal liver cells into lethally irradiated hosts, developed severe osteopenia, reduced lymphopoiesis and enhanced mobilization of hematopoietic stem and progenitor cells when BM cells were completely substituted by Rela-deficient cells. Rela −/− hematopoietic stem cells from fetal liver had normal hematopoietic ability, but those harvested from the BM of osteopenic Rela −/− chimeric mice had reduced repopulation ability, indicating impairment of the microenvironment for the hematopoietic niche. Osteopenia in Rela −/− chimeric mice was due to reduced bone formation, even though osteoblasts differentiated from host cells. This finding indicates impaired functional coupling between osteoblasts and hematopoietic stem cell-derived cells. Rela-deficient BM macrophages exhibited an aberrant inflammatory phenotype, and transplantation with wild-type F4/80 + BM macrophages recovered bone formation and ameliorated lymphopoiesis in Rela −/− chimeric mice. Therefore, RELA in F4/80 + macrophages is important both for bone homeostasis and for maintaining the hematopoietic niche after lethal irradiation and hematopoietic stem cell transplantation.
Introduction
Despite its solid nature, bone is actually in a constant state of dynamic turnover known as remodeling (1) . Osteoblasts differentiated from mesenchymal stem cells (MSCs) form bone matrix, and osteoclasts derived from hematopoietic stem cells (HSCs) resorb bone. These two types of highly specialized cells arise from different origins and coordinately act to maintain bone structure and strength. Imbalance between bone formation and resorption results in metabolic disorders such as osteoporosis and osteopetrosis. The 'coupling' of the functions of osteoblasts and osteoclasts is important for bone homeostasis. In addition to the importance of functional coupling between osteoblasts and osteoclasts (1, 2) bone marrow (BM) macrophages are important for supporting bone formation (3) (4) (5) .
Bone provides the microenvironment for hematopoiesis. Several types of cells, including osteoblasts, sinusoidal endothelial cells, reticular stromal cells, Nestin + MSCs and nerve cells, have been identified and characterized as components of the HSC niche (6) (7) (8) (9) (10) (11) (12) (13) . During the past few years, BM macrophages have been added as components of the HSC niche (14) . The depletion of BM macrophages induces the down-regulation of CXCL12 in Nestin + niche cells and the egress of hematopoietic stem and progenitor cells (HSPCs) to the bloodstream (15) . However, the depletion of macrophages inhibits the mobilization of HSPCs triggered by administration with G-CSF (16) . The expression of G-CSF receptor exclusively on macrophages is sufficient to induce the mobilization of HSPCs (4) . Moreover, activated macrophages that express α-smooth muscle actin, a rare BM population, maintain HSPCs and protect them from exhaustion during steady-state and stress situations (17) . Therefore, BM macrophages play important roles in both bone remodeling and hematopoiesis. According to the T h 1-T h 2 paradigm of T lymphocyte function, macrophages had been subdivided into M1 and M2 macrophages (18) , but currently they are functionally classified as classically activated macrophages, woundhealing macrophages and regulatory macrophages (19) . Classically activated macrophages are M1 macrophages and produce high levels of pro-inflammatory cytokines and mediators; these cells are important for host defense but cause tissue damage. Wound-healing macrophages produce arginase, which converts arginine to ornithine, a precursor of polyamines and collagen, thereby contributing to the production of the extracellular matrix (20) . Regulatory macrophages produce immunosuppressive cytokines to dampen the immune response. Wound-healing and regulatory macrophages are classified as M2 macrophages. Switching from inflammatory M1 to wound-healing or regulatory M2 may be important for the termination of inflammation (19) .
NF-κB, a transcription factor important for immune responses, cell survival and cellular development, is composed of five different molecules: RELA, RELB, c-REL, NF-κB1 and NF-κB2 (21) . In addition, NF-κB is important for lymphocyte development and bone homeostasis (21, 22) . Because mice deficient in RELA die at embryonic day (ED) 14.5, its function has been investigated by using fetal liver (FL) chimeric mice. Although the reports regarding lymphopoiesis in Rela −/− chimeric mice are conflicting (23, 24) , peripheral Rela-deficient lymphocytes are nearly normal in function, antibody production, cytokine expression and T h 1-T h 2 polarization (23, 25) . In contrast, Rela-deficient macrophages exhibit marked dysfunction, including reduced production of inflammatory cytokines, high sensitivity to apoptotic stimuli and reduced killing of intracellular parasites (25) (26) (27) . Therefore, the absence of RELA leads to dysfunctions of myeloid cells.
In the current study, we found that many Rela −/− chimeric mice developed osteopenia due to reduced bone formation. The mice whose BM cells were substituted completely by FL-derived cells developed severe osteopenia, reduced lymphopoiesis and granulocytosis and enhanced mobilization of HSPCs. Rela −/− HSCs themselves are not defective in lymphopoiesis, but the HSC niche is impaired in Rela −/− chimeric mice. The impaired bone formation of Rela −/− chimeric mice is due to a defect in Rela-deficient macrophages, because cotransplantation with wild-type macrophages rescued the reduced bone formation, and lymphopoiesis began to recover. Taking together these findings, we discuss the role of BM macrophages in bone formation and the HSC niche after lethal irradiation.
Methods

Mice and FL cell engraftment
Rela-deficient mice, whose background is C57BL/6-CD45.2, were generated previously (23) . FLs were harvested from ED13.5 embryos. To prepare chimeric mice, FL cells from a single fetus were injected intravenously into an 8-to 12-week-old C57BL/6-CD45.1 male host mouse (RBRC. 00144) obtained from the Experimental Animal Division, RIKEN BioResource Center. Before being injected with FL cells, host mice received 900 rad of γ irradiation. All animal procedures were conducted in accordance with the Regulations for Animal Experiments of RIKEN. Our experimental protocols were approved by the Animal Experiments Committee of RIKEN Tsukuba Institute.
Bone analyses
More than 4 months after transplantation, mice were euthanized, and tibiae and femora were dissected. All bones were fixed in PBS-buffered paraformaldehyde (4%) for 3 days at 4°C and washed with PBS for further analyses. The bone mineral density (BMD) of tibiae and femora was measured by using dual-energy X-ray absorptiometry (model DCS-600R; Aloka, Tokyo, Japan). Three-dimensional reconstructed images were obtained by microfocal-computed tomography (μCT) (ScanXmate-E090; Comscan, Yokohama, Japan). For bone histomorphometry, we used mice 1 month after transplantation. At 9 and 2 days before euthanasia, mice were injected with calcein subcutaneously at a dose of 20 mg kg −1 of body weight. After fixation, tibiae were embedded in the mixture of methyl methacrylate and 2-hydroxyethyl methacrylate resin, and 3-μm sagittal sections were prepared. Sections were stained with tartrate-resistant acid phosphatase and counterstained with toluidine blue. The numbers of osteoclasts, osteoclast surfaces, calcein single-and double-labeled surfaces and total bone surfaces in both primary and secondary spongiosa of the metaphyseal portion of tibiae were measured by using an image-analyzing system (KS400; Carl Zeiss, Oberkochen, Germany).
Induction of macrophages and osteoclast-like cells in vitro and their analysis
M1 and M2 macrophages were induced by culturing BM cells from chimeric mice in PRMI-1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 20% fetal bovine serum in the presence of 10 ng ml −1 GM-CSF (WAKO Pure Chemical Industries, Osaka, Japan) or M-CSF (WAKO Pure Chemical Industries), respectively, for 5 days. Then M1 cells were stimulated with 100 ng ml −1 IFN-γ (e-Bioscience, San Diego, CA, USA) and M2 cells were stimulated with 10 ng ml −1 IL-4 plus 10 ng ml −1 IL-13 (e-Bioscience) for 6 h. Primary osteoblasts were obtained from the calvariae of newborn ddY mice after digestion with PBS containing 0.1% collagenase (WAKO Pure Chemical Industries) and 0.2% Dispase II (EIDIA Company, Tokyo, Japan). After expansion through culture in α-MEM (WAKO Pure Chemical Industries), primary osteoblasts were frozen at −80°C. BM cells (5 × 10 4 per well) were co-cultured with 5 × 10 3 osteoblasts in 10 −8 M 1α,25-dihydroxyvitamin D 3 (1α,25(OH) 2 D 3 ) in 96-well plates for the indicated number of days. To determine receptor activator of nuclear factor-κB (RANK) expression by using FACS, BM cells were cultured for 3 days in 50 ng ml −1 M-CSF (WAKO Pure Chemical Industries). Mature osteoclast-like cells (OCLs) were isolated as described previously (28) . Briefly, OCLs were induced through co-culture for 6 days with primary osteoblasts in the presence of 10 −8 M 1α,25(OH) 2 D 3 and 10 −6 M prostaglandin E 2 (PGE 2 ) (Cayman Chem., Ann Arbor, MI, USA) in 100-mm collagen-coated dishes (Nitta Gekatin, Osaka, Japan). OCLs then were removed from the dishes by treatment with 0.2% collagenase, replated in 4-well plates and incubated for 8 h. Osteoblasts then were removed by treatment with PBS containing 0.001% Pronase E (from Streptomyces griseus; Sigma, St Louis, MO, USA) and 0.02% EDTA. For pit formation assays, OCLs were induced on dentine slices by co-culture with osteoblasts for 6 days, after which the slices were stained with 1% toluidine blue. The area and depth of resorbed regions were measured by using a color laser 3D profile microscope (model VK8500; Keyence, Itasca, IL, USA).
Colony-forming assay
BM, spleen and peripheral blood were harvested, and single-cell suspensions were prepared. After hemolysis with ammonium chloride, BM cells (2 × 10 4 per dish), splenocytes or peripheral blood cells (1 × 10 5 per dish) were plated in methylcellulose medium supplemented with erythropoietin, IL-3, IL-6 and stem cell factor (Methocult GF M3434; Stem Cell Technology, Vancouver, Canada) according to the manufacturer's instructions. Colonies were counted after 12 days of culture.
Flow cytometric analysis and cell sorting
The following conjugated mAbs (all purchased from e-Bioscience) were used: anti-CD45R (B220)-PE (RA3-6B2), antiCD11b-FITC (M1/70), anti-Gr-1-PE/Cy7 and -PE (RB6-8C5), anti-CD90.2 (Thy1.2)-FITC (53-2.1), anti-CD117 (c-Kit)-PE and -APC (2B8), anti-CD127 (IL7R-α)-PE (A7R34), antiSca-1-FITC (D7), streptavidin-PE/Cy7, and biotinylated mAbs: anti-CD3e (145-2C11), anti-CD11b (M1/70), antiTer119 (TER119), anti-Gr1 (RB6-8C5), anti-CD45R (RA3-6B2), and anti-RANK (R12-31). Anti-Ter119-FITC (TER-119), anti-CD11c-PE/Cy7 (N418), anti-CD45.2-APC/Cy7 (104), anti-CD45.1-Alexa Fluor 700 (A20), anti-F4/80-APC (BM8), anti-Sca-1-PE/Cy7 (D7), and streptavidin-PerCP/Cy5.5 and -Brilliant Violet 510 were purchased from BioLegend (San Diego, CA, USA). Before measurements or sorting, we added 7AAD (BioLegend) to eliminate dead cells. Flow cytometric analyses were performed by using a BD LSRFortessa (Franklin Lakes, NJ, USA), and cell sorting was performed by using a BD FACSAria III.
Quantitative RT-PCR
Femora were snap-frozen in liquid nitrogen and then crushed. Total RNA was isolated from femora and sorted cells by using Trizol (Invitrogen) and treated with DNase I (Invitrogen). cDNA was synthesized by using PrimeScript II reverse transcriptase (Takara, Kyoto, Japan) or SuperScript VILO (Invitrogen) according to the manufacturer's instructions.
Quantitative RT-PCR analysis was performed by using SYBR Premix Ex Taq II (Takara) and a LightCycler 2.0 (Roche, Basel, Switzerland). For normalization, the expression of Hprt was measured as an endogenous reference gene. The primers specific for mouse are shown in Supplementary 
ELISA
Serum levels of calcium and C-reactive protein (CRP) were measured by using ELISA kits purchased from Cayman Chemical (Ann Arbor, MI, USA). The levels of IL-1α, IL-1β and IL-6 were quantified by using ELISA kits from e-Bioscience. The phosphate level was quantified by using a malachite green phosphate assay kit from BioAssay Systems (Hayward, CA, USA). TNF was measured by using a bioassay system based on cytotoxic activity against L929 cells (29) .
Immunohistochemical analysis
Bone samples were fixed with 4% paraformaldehyde and equilibrated in 30% sucrose-PBS. Fixed samples were embedded in SCEM-(L1) (Section LAB, Hiroshima, Japan) and frozen in cooled hexane. Sections of undecalcified tibiae were generated according to Kawamoto's film method (Section LAB). The 5-μm sections were blocked with 3% BSA in PBS and then stained with anti-F4/80-FITC and purified rabbit anti-mouse osteocalcin polyclonal antibody (M173) (Takara). For a secondary antibody, Alexa Fluor 594-conjugated goat anti-rabbit IgG (H+L) (Invitrogen) was used. Cell nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen). Sections were mounted by using Mounting Medium for Fluorescence with DAPI (Vectashield, Burlingame, CA, USA) and were viewed by using a laser scanning microscope (LSM 710; Carl Zeiss).
Results
Rela-chimeric mice develop osteopenia due to reduced bone formation
We prepared FL chimeric mice by transferring ED13.5 FL cells from Rela −/− mice or their Rela +/+ littermates into lethally irradiated (900 rad) CD45.1 + C57BL6/J host mice. Most of the Rela −/− FL chimeric mice developed osteopenia, which first became apparent at 4 months after transplantation. μCT images of tibiae and femora showed that the trabecular bone volume was decreased and cortical bone was thinner in Rela −/− chimeric mice than in Rela +/+ controls (Fig. 1A ). In addition, BMD was significantly decreased in the tibiae and femora of Rela −/− chimeric mice compared with Rela +/+ chimeric mice (Fig. 1B) . Because the osteoclasts of the chimeric mice arise from the transferred FL cells, we wondered whether hyper-differentiation into osteoclasts induced the observed osteopenia. Compared with those in controls, the number of osteoclasts per bone surface (No. Oc/BS) and the percentage of osteoclast surface per bone surface (Oc.S/ BS) did not differ significantly between Rela +/+ and Rela −/− chimeric mice (Fig. 1C) . We also examined bone formation. Both the mineralizing surface per bone surface (MS/BS) and bone formation rate (BFR) were markedly decreased in Rela −/− chimeric mice (Fig. 1D) , even though the osteoblasts
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were derived from wild-type MSCs. We estimated the mRNA expression of differentiation markers of osteoblasts and osteoclasts in bone (Fig. 1E) Figure 1A , available at International Immunology Online). This effect may be sufficient to account for the slight enhancement of osteoclast differentiation in vivo but likely is insufficient to account for the severe osteopenia of Rela −/− chimeric mice. The frequencies of osteoclast precursors, which were detected by assessing RANK expression, were comparable between Rela-deficient and -sufficient cells both before and after M- Figure 1E, 
Rela-sufficient cells (Supplementary
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and spleen were comparable between Rela −/− 1 and Rela +/+ chimeric mice ( Fig. 3B and Supplementary Figure 4A , available at International Immunology Online). Rela −/− 2 mice showed the highest chimerism in BM among control mice and the three Rela −/− phenotypes (Fig. 3A) , with a minimal value of 98% and an average of 98.6% BM chimerism. In addition, Rela −/− 2 mice had high numbers of peripheral HSPCs (Fig. 3B ) and the greatest number of KSL cells in spleen (Supplementary Figure 4A , available at International Immunology Online). Furthermore, the numerous colony-forming unit-erythroid (CFU-E) colonies and Ter119 + erythroblasts generated from spleen demonstrate the presence of extramedullary erythropoiesis in Rela −/− 2 mice (Supplementary Figure 4B and C, available at International Immunology Online). Therefore, Rela −/− 2 mice have high mobilization of HSPCs.
In contrast, mice of the Rela −/− 3 phenotype had the lowest chimerism (mean value, 50.5%) in BM among the three Rela −/− phenotypes, having fewer CD45.2 + BM cells and splenocytes (Fig. 3A) and fewer HSPCs in both BM and spleen (Fig. 3B) .
Looking at the bone phenotypes, we found that Rela −/− 2 mice developed the most severe osteopenia among the three types of Rela −/− mice, and Rela −/− 3 were less severely osteopenic than were Rela −/− 2 mice. In contrast to this finding and in parallel with their hematopoietic phenotype, Rela −/− 1 mice had no symptom of osteopenia (Fig. 3D) . Among the (Fig. 4) . There was no significant difference in the number of myeloid cells between these genotypes. Therefore, these results indicate that RELA deficiency did not hamper the hematopoietic ability of HSCs. In addition, BMD did not differ significantly between Rela +/+ and Rela −/− chimeric mice (Fig. 4D) . Therefore, (Fig. 6A) ; in contrast, the percentage and number of F4/80 + cells were significantly increased in Rela −/− 2 mice compared with control spleen (Fig. 6B) . Therefore, F4/80 + cells differentiated sufficiently but localized poorly to the BM in Rela −/− 2 mice. We observed the localization of F4/80 + macrophages and osteocalcin-expressing cells in BM. Compared with those in wild-type intact mice, active osteoblasts, which were positive for osteocalcin, were reduced in number even in control Rela +/+ chimeric mice ( Fig. 6C and D, and data not shown). In Rela −/− 2 chimeric mice, the only osteocalcin-specific signal seen was that in the epiphyseal region; there was none in cortical bone (Fig. 6E and F) . F4/80 + macrophages overlaid osteocalcin + cells in Rela +/+ chimeric mice, and other F4/80 + cells were scattered throughout the BM (Fig. 6C and D) . In contrast, the number of F4/80 + cells was markedly reduced in Rela −/− chimeric mice; these few F4/80 + cells were near the bone surface (Fig. 6E and F) .
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In parallel with the reduction of F4/80 + cells in the BM of Rela −/− 2 mice, CD11b + F4/80 + CD11c − M2 macrophages were significantly reduced in percentage and number (Fig. 6G) (Fig. 6H) . However, other M1 genes, such as Il6 and Ptgs2 (the gene for COX2), were somewhat down-regulated in Rela −/− F4/80 + cells, and the expression of Tnf was comparable to that in Rela +/+ cells. In contrast, the expression of Arg1 and Ym1, marker genes of M2, was significantly reduced in Rela −/− F4/80 + cells. The expression of Ptgs1, a gene that produces PGE 2 through a different pathway from that of Ptgs2, and Osm, the gene for oncostatin M, did not differ between Rela +/+ and Rela −/− chimeric mice. FACS and gene expression analyses indicated that M2 macrophages were reduced in the BM of the osteopenic Rela −/− chimeric mice, and abnormal M1 macrophages, in which Nos2 only was aberrantly up-regulated, were activated.
The aberrant activation of M1 macrophages was seen only in vivo, because M1 macrophages that were induced in vitro by culturing the BM cells of Rela-deficient chimeric mice showed up-regulation of all M1 genes (Supplementary Figure 5A , available at International Immunology Online). The expression levels of Nos2, Ptgs2 and Tnf were much higher in Rela-deficient cells than in Rela-sufficient cells, suggesting that the deficiency of RELA may make cells susceptible to inflammatory stimuli. In contrast, the expression of M2 genes did not differ significantly between Rela-deficient and -sufficient cells (Supplementary Figure 5B , available at International Immunology Online). (Fig. 6A) . Moreover, osteopenic Rela −/− 2 mice had 10-fold less number −/− chimeric mice had markedly reduced expression of mature osteoblast markers, whereas that of the marker of preosteoblasts was intact. The osteoblasts may be inhibited during the final maturation process rather than at their differentiation. Although we do not know the exact mechanism through which osteoclasts were normally induced in the bone of the osteopenic Rela −/− 2 mice, the expression of RANK ligand and M-CSF was also intact (data not shown). RANK ligand is expressed not only in osteoblasts but also in osteocytes (33) . Overall osteoclastogenesis occurs normally in Rela −/− 2 mice. Although Rela-deficient HSCs in FL reproduced normal hematopoietic populations when they were cotransplanted with wild-type BM cells, their hematopoietic property may be altered by the deficiency of RELA as described by Stein and Baldwin (34) . They used conditional knockout mice having (35) . The deficiency of RELA in BM macrophages may impair the hematopoietic environment and alter HSC function. In our study, Rela-deficient FL has a higher percentage of CD11b + Gr1 + cells than does Rela-sufficient FL. Granulocytosis easily may occur in mice that are deficient in the classical pathway of NF-κB, as seen in Ikk-β-deficient mice (36) .
Perhaps osteoblastic niche cells are impaired in Rela −/− chimeric mice. The phenotype of Rela −/− 2 mice is very similar to that of osteoblast-depleted mice (37) . In the current study, we performed transplantations after lethal irradiation of host mice. Under these conditions, the BM microenvironment is altered and is not identical to that of the homeostatic state (14) . Although osteoblasts, which are derived from host MSCs, are considered to be more resistant to ionizing radiation than are hematopoietic cells, both osteoblasts and MSC-derived cells are known to be damaged and removed after irradiation (38) and to rapidly rebound thereafter (39, 40) . In our experimental system, osteoblasts and other MSC-derived cells may similarly be damaged and then recover after irradiation. In fact, Nos2 expression is up-regulated in BM immediately after lethal irradiation followed by wild-type FL or BM transplantation and then gradually declines (data not shown), suggesting that transient inflammation occurs immediately after transplantation and then heals. In the case of Rela −/− 2 mice, aberrant expression of Nos2 was maintained, but the expression of the other M1 genes was decreased. In particular, a decrease in the expression of COX2, an inducible enzyme in the production of PGE 2 , may hamper the differentiation of M2 macrophages, because PGE 2 is required for switching from inflammatory M1 macrophages to healing M2 macrophages (41, 42) . The observed osteopenia and impairment of the HSC niche may result from the aberrant activation of M1 macrophages and the absence of a 'switch' to convert M1 to M2, resulting in failure of healing from irradiation-induced damage. PGE 2 , itself, induces osteoblasts to form bone matrices (43) (44) (45) (46) (47) (48) and improves the hematopoietic activity of HSPCs (49) (50) (51) . The reduced expression of IL-6 may be responsible to impaired bone formation because it has osteoblastogenic activity (52, 53) . To address whether mice whose macrophages are Rela-deficient develop osteopenia in the absence of irradiation, we are preparing myeloidspecific knockout mice.
In the current study, we focused on the microenvironment of the HSC niche of Rela −/− chimeric mice. We provide the first observation regarding the HSC niche in NF-κB-deficient chimeric mice. Rela −/− chimeric mice developed severe osteopenia when their BM cells were nearly completely replaced by FL-derived cells. We cannot exclude the possibility that MSCs from FL differentiate into osteoblasts in the BM, as do BM-derived MSCs (39, 40) . In addition, Rela-deficient MSCs may not have the potential to differentiate to osteoblasts or to form bone nodules. However, studies using mice whose osteoblasts were transduced with an NF-κB inhibitor revealed that the activation of NF-κB inhibits bone formation (54) . Our current study provides new insights into the role of BM macrophages in restoring the HSC niche after irradiation and in HSC transplantation.
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